1250-95-9

1250-95-9 is a lipid of Sterol Lipids (ST) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 303 references associated with 1250-95-9 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 1250-95-9

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 1250-95-9

MeSH term MeSH ID Detail
Hyperlipoproteinemia Type III D006952 4 associated lipids
Hyperlipoproteinemias D006951 15 associated lipids
Total 2

NCBI Entrez Crosslinks

All references with 1250-95-9

Download all related citations
Per page 10 20 50 100 | Total 60
Authors Title Published Journal PubMed Link
pmid:
Sevanian A et al. Lipid epoxide hydrolase in rat lung preparations. 1980 Biochim. Biophys. Acta pmid:7407199
Black HS Analysis and physiologic significance of cholesterol epoxide in animal tissues. 1980 Lipids pmid:7421427
Petrakis NL et al. Cholesterol and cholesterol epoxides in nipple aspirates of human breast fluid. 1981 Cancer Res. pmid:7237447
Raicht RF and Cohen BI Sterol metabolism in the rat. Effect of cholesterol and cholesterol-alpha-epoxide on sterol metabolism in rats fed liquid diets. 1981 Biochim. Biophys. Acta pmid:7326255
Meyer DJ and Ketterer B 5 alpha,6 alpha-Epoxy-cholestan-3 beta-ol (cholesterol alpha-oxide): A specific substrate for rat liver glutathione transferase B. 1982 FEBS Lett. pmid:7160489
Baranowski A et al. Connective tissue responses to oxysterols. 1982 Atherosclerosis pmid:7066074
Sporer A et al. Epoxycholesterols in secretions and tissues of normal, benign, and cancerous human prostate glands. 1982 Urology pmid:6181602
Watabe T et al. Epoxidation of cholesterol by hepatic microsomal lipid hydroperoxides. 1982 Biochem. Biophys. Res. Commun. pmid:7150318
Levin W et al. Distinct rat hepatic microsomal epoxide hydrolases catalyze the hydration of cholesterol 5,6 alpha-oxide and certain xenobiotic alkene and arene oxides. 1983 Arch. Biochem. Biophys. pmid:6401984
Watabe T et al. A mechanism for epoxidation of cholesterol by hepatic microsomal lipid hydroperoxides. 1984 Biochim. Biophys. Acta pmid:6466699
Sevanian A and Peterson AR Cholesterol epoxide is a direct-acting mutagen. 1984 Proc. Natl. Acad. Sci. U.S.A. pmid:6588383
Higley NA et al. Comparative atherogenic effects of cholesterol and cholesterol oxides. 1986 Atherosclerosis pmid:3801085
Bascoul J et al. Intestinal absorption and fecal excretion of 5,6 alpha-epoxy-5 alpha-cholesta-3 beta-ol by the male Wistar rat. 1986 Lipids pmid:3821388
Sevanian A and McLeod LL Catalytic properties and inhibition of hepatic cholesterol-epoxide hydrolase. 1986 J. Biol. Chem. pmid:3941086
Gruenke LD et al. Breast fluid cholesterol and cholesterol epoxides: relationship to breast cancer risk factors and other characteristics. 1987 Cancer Res. pmid:3652048
Raaphorst GP et al. Effect of cholesterol alpha and beta epoxides on cell killing and transformation. 1987 Biochem. Pharmacol. pmid:3606646
Jacobson MS Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indian immigrant populations. 1987 Lancet pmid:2887943
Chang CC et al. Effect of cholesterol epoxides on the inhibition of intercellular communication and on mutation induction in Chinese hamster V79 cells. 1988 Mutat. Res. pmid:2849716
Maerker G et al. Reaction of cholesterol 5,6-epoxides with simulated gastric juice. 1988 Lipids pmid:3185108